Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)

76Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS). TXAS, an enzyme of the arachidonic acid cascade, produces thromboxane A2 (TXA2). Platelets from subjects with GHDD showed a specific deficit in arachidonic acid-produced aggregation. We also found that TXAS and TXA2 modulated expression of TNFSF11 and TNFRSF11B (encoding RANKL and osteoprotegerin (OPG), respectively) in primary cultured osteoblasts. © 2008 Nature Publishing Group.

Cite

CITATION STYLE

APA

Geneviève, D., Proulle, V., Isidor, B., Bellais, S., Serre, V., Djouadi, F., … Cormier-Daire, V. (2008). Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome). Nature Genetics, 40(3), 284–286. https://doi.org/10.1038/ng.2007.66

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free